Publication | Open Access
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.
213
Citations
0
References
1990
Year
ApoptosisImmunologyCell DeathImmunologic MechanismCell ProliferationImmunotherapyCancer BiologyMultilineage Cd38 MoleculeCell RegulationUnique PathwayRadiation OncologyCell SignalingHealth SciencesCell ActivationMolecular PathwayAutoimmunityCell BiologyTumor MicroenvironmentSignal TransductionCd38 MoleculeA10 MabCd3 Activation PathwaysCellular Immune ResponseMedicine
We report clear evidence that the interaction of the CD38 molecule with the specific mAb A10 on normal human cells and lines modulates the expression of surface activation markers relevant to T, NK, and plasma cell biology and functions. Moreover A10 mAb binding is followed by proliferation effects on all the target cells analyzed, and the phenomenon is accessory cell and IL-2 dependent. The effects of A10 mAb synergizing both CD2 and CD3 activation pathways indicate that CD38 signal transduction mechanism(s) are apparently different from the aforementioned. Nevertheless the decreased A10-driven proliferation after CD3-Ti modulation suggests a possible functional interdependence between these activation pathways. Taken together, the results indicate that the CD38 molecule might play a physiologic role in T, NK, and plasma cell regulation.